[1,1'-Biphenyl]-4,4'-dicarboxylic acid
Common Name: |
[1,1'-Biphenyl]-4,4'-dicarboxylic acid |
IUPAC Name: |
4-(4-carboxyphenyl)benzoic acid |
Molecular Formula: |
C14H10O4 |
SMILES: |
C1=CC(=CC=C1C2=CC=C(C=C2)C(=O)O)C(=O)O |
Inchi: |
1S/C14H10O4/c15-13(16)11-5-1-9(2-6-11)10-3-7-12(8-4-10)14(17)18/h1-8H,(H,15,16)(H,17,18) |
Inchi Key: |
NEQFBGHQPUXOFH-UHFFFAOYSA-N |
Cas No: |
84787-70-2 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
242.23 |
Mass (g/mol) |
242.058 |
Molar Refractivity |
65.80 |
Net Charge |
-2 |
HBD |
2 |
HBA |
4 |
Rt Bonds |
3 |
Rings |
2 |
TPSA |
74.60 |
Hetero Atoms |
4 |
Heavy Atoms |
18 |
Aromatic Heavy Atoms |
12 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
|
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.00 |
LogP |
2.75 |
iLOGP |
1.53 |
XLOGP3 |
3.28 |
WLOGP |
2.75 |
MLOGP |
2.68 |
ESOL Log S |
-3.70 |
ESOL Solubility (mg/ml) |
0.048 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-4.52 |
Ali Solubility (mg/ml) |
0.01 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-3.67 |
Silicos-IT Solubility (mg/ml) |
0.05 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.45 |
Bioavailability Score |
0.85 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.733 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
0.84 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
1 |
Androgen Receptor Binding |
1 |
Aromatase Binding |
1 |
Estrogen Receptor Binding |
1 |
Glucocorticoid Receptor Binding |
1 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |